Vitamin Shoppe Inc. (NYSE:VSI) traded down 2.3% on Friday . The stock traded as low as $26.71 and last traded at $26.75, with a volume of 78,767 shares. The stock had previously closed at $27.37.

Several research analysts have recently commented on the stock. Goldman Sachs Group Inc. lowered shares of Vitamin Shoppe to a “hold” rating in a report on Saturday, April 30th. Macquarie reaffirmed a “neutral” rating and issued a $40.00 price target on shares of Vitamin Shoppe in a report on Thursday, May 5th. Sterne Agee CRT reaffirmed a “neutral” rating on shares of Vitamin Shoppe in a report on Monday, May 16th. Jefferies Group reaffirmed a “hold” rating on shares of Vitamin Shoppe in a report on Thursday, August 4th. Finally, Zacks Investment Research lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Wednesday, August 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $32.82.

The company has a market cap of $634.17 million and a P/E ratio of 15.75. The company has a 50 day moving average price of $29.22 and a 200-day moving average price of $29.61.

Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.59 by $0.04. During the same period last year, the company posted $0.57 EPS. The firm had revenue of $332.70 million for the quarter, compared to the consensus estimate of $331.58 million. The business’s quarterly revenue was up 3.2% on a year-over-year basis. Analysts anticipate that Vitamin Shoppe Inc. will post $2.17 earnings per share for the current fiscal year.

In other Vitamin Shoppe news, Director Guillermo Marmol acquired 1,000 shares of the company’s stock in a transaction dated Tuesday, May 31st. The stock was bought at an average price of $30.23 per share, for a total transaction of $30,230.00. Following the purchase, the director now owns 1,470 shares in the company, valued at approximately $44,438.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

An institutional investor recently bought a new position in Vitamin Shoppe stock. Employees Retirement System of Texas acquired a new position in shares of Vitamin Shoppe Inc. (NYSE:VSI) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 39,000 shares of the company’s stock, valued at approximately $1,275,000. Employees Retirement System of Texas owned 0.14% of Vitamin Shoppe as of its most recent filing with the SEC.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.